spk-8011
Gene therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Dec 1, 2016 (NCT03003533)
Timeline
Indications
Studied for
Mechanism of action
- Coagulation factor VIIISupplementation
F8 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- spk-8011
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06297486 | Phase 3 | Mar 13, 2024 | Spark Therapeutics |
| NCT03003533 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2016 | Spark Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Spark Therapeutics | For profit | 2 | 2 | 2 | 2016 |
1 organizations
Page 1 / 1